Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Dec. 18, 1996

Novel GABA uptake inhibitors from Novo Nordisk

Dec. 18, 1996

Glycine therapy as a potential new approach to schizophrenia Rx

Dec. 17, 1996

Rizatriptan goes head-to-head with sumatriptan in migraine patients

Dec. 17, 1996

Cortex notified of broad patent covering calpain inhibitors

Dec. 17, 1996

Acea describes candidate neuroprotectant

Dec. 16, 1996

Neurogen and Pfizer extend GABA-based collaboration

Dec. 16, 1996

Eisai describes selective dopamine D3 antagonists

Dec. 16, 1996

DuPont Merck evaluates new candidate cognition enhancer

Dec. 13, 1996

Therapeutically active cysteine proteinase inhibitors described by Synphar

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...